“…We wanted to assess the role of these two polymorphisms in AITDs, as in the current literature they were more frequently responsible for endocrinopathies, such as type 2 diabetes, obesity, insulin resistance, metabolic syndrome, anorexia nervosa. The other polymorphism, such as rs34911341 C4T, is rare [4][5][6][7][8].…”